Literature DB >> 17048786

[Psychiatric comorbidity in veterans with chronic PTSD treated at Center for Crisis Intervention, Zagreb University Hospital Center].

Darko Marcinko1, Zivko Malnar, Berislav Tentor, Mladen Loncar, Sanda Radanović-Corić, Spiro Janović, Veljko Dordevic, Ljubomir Hotujac.   

Abstract

UNLABELLED: Epidemiological and clinical studies provide evidence that veterans with chronic PTSD can be at risk of relapse with respect to a number of high-risk behaviors, including attempted suicide, violence, and misuse of alcohol and drugs. AIM, PATIENTS AND METHODS: The aim of our study was to assess the prevalence of psychiatric comorbidity in veterans with chronic PTSD treated at Center for Crisis Intervention, Zagreb University Hospital Center, for 4 years. The diagnosis of PTSD and comorbid psychiatric diagnosis were confirmed according to DSM-IV criteria. RESULTS AND DISCUSSION: Study results showed PTSD without comorbid psychiatric diagnosis to persist in 25.3%, and PTSD with comorbid psychiatric diagnosis in 74.7% of study subjects. The most common psychiatric disorders were depression, personality disorders, and alcoholism.
CONCLUSION: It is important to recognize other comorbid disorders because of the increased risk of suicidal behavior. Accordingly, therapeutic intervention should be adjusted to each individual case.

Entities:  

Mesh:

Year:  2006        PMID: 17048786

Source DB:  PubMed          Journal:  Acta Med Croatica        ISSN: 1330-0164


  2 in total

1.  Pattern of cognitive impairment in older veterans with posttraumatic stress disorder evaluated at a memory disorders clinic.

Authors:  R Scott Mackin; Julia A Lesselyong; Kristine Yaffe
Journal:  Int J Geriatr Psychiatry       Date:  2011-12-23       Impact factor: 3.485

2.  The Connection between Alexithymia and Somatic Morbidity in a Population of Combat Veterans with Chronic PTSD.

Authors:  Zorana Kusevic; Marta Civljak; Tea Vukusic Rukavina; Goran Babic; Mladen Loncar; Bjanka Vuksan Cusa; Rudolf Gregurek
Journal:  Acta Inform Med       Date:  2013-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.